Shareholders Equity ratio Analysis of Corvus Pharmaceuticals Inc - Deep Dive


Shareholders Equity of CRVS
Dec-23
84.92
Excellent Shareholders Equity
Dec-22
82.23
Excellent Shareholders Equity
Growth
3.27
%
Shareholders Equity Analysis of Corvus Pharmaceuticals Inc
Shareholder to Equity Ratio of Corvus Pharmaceuticals Inc with value of 84.92 indicates that shareholders own a High proportion of the assets of the company.
Shareholders Equity Ratio of CRVS has grown by 3.27 % Compared to previous Financial Year.
Shareholders Equity Ratio with value of 88.77 was highest in Year Dec-21 in last Five Years.
Shareholders Equity Ratio with value of 82.23 was lowest in Year Dec-22 in last Five Years.
Latest Shareholders Equity Ratio with value of 84.92 is lower than Average Shareholders Equity of 85.06 in last five years.
Other Shareholders Equity Related Info of CRVS that may interest you.
Corvus Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
CRVS1.932.04 5.39 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
No Significant Stability
FY - Historical Shareholders Equity of Corvus Pharmaceuticals Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Shareholders Equity84.9282.2388.7784.3685.0193.3289.51
Change3.27 %-7.36 %5.23 %-0.775 %-8.90 %4.26 %-5.53 %
You are view first 7 Records. Log in to view all 10 in Premium view
FY Chart of Shareholders Equity of Corvus Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)